journal article·2018-01-26Open access

Advances in Degradable Embolic Microspheres: A State of the Art Review

Jensen Doucet, Lauren Kiri, Kathleen O’Connell, Sharon Kehoe, Robert Lewandowski, David Liu, Robert Abraham, Daniel Boyd

Abstract

Considerable efforts have been placed on the development of degradable microspheres for use in transarterial embolization indications. Using the guidance of the U.S. Food and Drug Administration (FDA) special controls document for the preclinical evaluation of vascular embolization devices, this review consolidates all relevant data pertaining to novel degradable microsphere technologies for bland embolization into a single reference. This review emphasizes intended use, chemical composition, degradative mechanisms, and pre-clinical safety, efficacy, and performance, while summarizing the key advantages and disadvantages for each degradable technology that is currently under development for transarterial embolization. This review is intended to provide an inclusive reference for clinicians that may facilitate an understanding of clinical and technical concepts related to this field of interventional radiology. For materials scientists, this review highlights innovative devices and current evaluation methodologies (i.e., preclinical models), and is designed to be instructive in the development of innovative/new technologies and evaluation methodologies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Vascular Anomalies and Treatments · Intracranial Aneurysms: Treatment and Complications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada

Department of Applied Oral Sciences, Faculty of Dentistry, 5981 University Avenue, P.O. BOX 15000, Halifax, NS B3H 4R2, Canada

ABK Biomedical Inc., Unit 32, 155 Chain Lake Drive, Halifax, NS B3S 1B3, Canada

Department of Radiology, Division of Vascular and Interventional Radiology, Fienberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Department of Radiology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada

Interventional Radiology and Diagnostic Imaging Department, Room 3316, Halifax Infirmary Site, QEII Health Sciences Center, 1796 Summer St, Halifax, NS B3H 3A7, Canada

References (57)

Show source-provided references
1. Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation
2. A novel resorbable embolization microsphere for transient uterine artery occlusion: A comparative study with trisacryl-gelatin microspheres in the Sheep Model10.1016/j.jvir.2014.06.025 ↗
3. Kessel, D., and Ray, C. (2010). Transcatheter embolization and therapy. Techniques in Interventional Radiology, Springer. [1st ed.].10.1007/978-1-84800-897-7 ↗
4. Food and Drug Administration Center for Devices and Radiological Health (2004). Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.
5. Kehoe, S., Amensag, S., Looney, M., Abraham, R.J., and Boyd, D. (2015). “Imageable” zinc-silicate glass microspheres for transarterial embolization: A renal artery embolization study. Biomed. Glasses, 1.10.1515/bglass-2015-0007 ↗
6. Resorbable biomaterials as bone graft substitutes10.1016/S1369-7021(10)70014-6 ↗
7. Williams, D. (2014). Essential Biomaterials Science, Cambridge University Press.10.1017/CBO9781139026086 ↗
8. Poly(lactic acid) fiber: An overview10.1016/j.progpolymsci.2007.01.005 ↗
9. An overview of Poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering10.3390/ijms15033640 ↗
10. Poly Lactic-co-Glycolic ACID (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
11. In vitro degradation behaviour of non-porous ultra-fine poly(glycolic acid)/poly(l-lactic acid) fibres and porous ultra-fine poly(glycolic acid) fibres10.1016/j.polymdegradstab.2005.04.015 ↗
12. Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms10.1002/jps.21176 ↗
13. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip10.1163/1568562041959991 ↗
14. Polymer degradation and drug delivery in PLGA-based drug–polymer applications: A review of experiments and theories10.1002/jbm.b.33648 ↗
15. Poly(lactic acid) modifications10.1016/j.progpolymsci.2009.12.003 ↗
16. A review of material degradation modelling for the analysis and design of bioabsorbable stents10.1007/s10439-015-1413-5 ↗
17. Bio-absorbable polymers in implantation—An overview
18. A preclinical study of the safety and efficacy of OcclusinTM 500 artificial embolization device in Sheep10.1007/s00270-011-0218-7 ↗
19. Revised 501(k) Summary for IMBiotechnologies Ltd. (2017, June 20). Occlusin 500 Artificial Embolization Device (Per 21CFR 807.92), Available online: https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093813.pdf.
20. Retrospective study of the impact of fellowship training on two quality and safety measures in uterine artery embolization10.1016/j.jacr.2013.09.020 ↗
21. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
22. Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: Case report10.1093/humrep/dei299 ↗
23. (2017, July 11). “Use of International Standard ISO-10993, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing” PDF, Available online: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm348890.pdf.
24. Merit Medical Systems, Inc. (2017, July 11). Embosphere Microspheres Brochure. Available online: https://www.merit.com/interventional-oncology-spine/embolotherapy/microspheres/embosphere-microspheres/#tab-id-2.
25. Swielim, G.E.A. (2006). ATLAS—Anatomy of Sheep, Ktab INC.
26. Veronese, F.M. (2009). PEG and PEG conjugates toxicity: Towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals. PEGylates Protein Drugs: Basic Science and Clinical Applications, Birkhauser Verlag.
27. Magnon, L., Laurent, A., Wassef, M., Bedouet, L., Louguet, S., Verret, V., and Servais, E. (2012). Implantable Swellable Bio-Resorbable Polymer. (Patent 2012/120138).
28. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model10.1016/j.jvir.2013.05.058 ↗
29. ASTM E11-17 (2017). Standard Specification for Woven Wire Test Sieve Cloth and Test Sieves, ASTM International. Available online: https://www.astm.org/Standards/E11.htm.
30. Ong, J.L., Appleford, M.R., and Mani, G. (2013). Introduction to Biomaterials: Basic Theory with Engineering Applications, Cambridge University Press.
31. Properties of the glomerular barrier and mechanisms of proteinuria10.1152/physrev.00055.2006 ↗
32. Nanosoft Polymers (2017, June 20). PLGA-PEG-PLGA. Available online: https://www.nanosoftpolymers.com/product/plga-peg-plga/.
33. Interaction of chitosan with natural or synthetic anionic polyelectrolytes. 1. The chitosan–carboxymethylcellulose complex10.1016/j.carbpol.2005.07.004 ↗
34. Bioresorbable Hydrogel Microspheres for Transcatheter Embolization: Preparation and in Vitro Evaluation10.1016/j.jvir.2011.06.010 ↗
35. In vitro enzymatic degradation kinetics of polymeric blends of crosslinked starch and carboxymethyl cellulose10.1002/pi.1878 ↗
36. Synthesis and characterization of carboxymethylcellulose-methacrylate hydrogel cell scaffolds10.3390/polym2030252 ↗
37. Synthesis and in vitro characterizations of porous carboxymethyl cellulose-poly(ethylene oxide) hydrogel film10.1186/s40824-015-0033-3 ↗
38. Biodegradation, biodistribution and toxicity of chitosan10.1016/j.addr.2009.09.004 ↗
39. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents10.1016/S0142-9612(02)00011-X ↗
40. Quantitative determination of chitinolytic activity of lysozyme using half-deacetylated chitosan as a substrate10.1016/j.carbpol.2011.03.009 ↗
41. The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo
42. Calibrated bioresorbable microspheres: A preliminary study on the level of occlusion and arterial distribution in a rabbit kidney model10.1016/j.jvir.2013.06.009 ↗
43. In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release10.1016/j.actbio.2013.02.017 ↗
44. Calibrated bioresorbable microspheres as an embolic agent: An experimental study in a rabbit renal model10.1016/j.jvir.2015.01.014 ↗
45. Chitin and chitosan polymers: Chemistry, solubility and fiber formation10.1016/j.progpolymsci.2009.04.001 ↗
46. Chitin and chitosan based polyurethanes: A review of recent advances and prospective biomedical applications10.1016/j.ijbiomac.2016.02.004 ↗
47. Chitin-based embolic materials in the renal artery of rabbits: Pathologic evaluation of an absorbable particulate agent10.1148/radiol.2361040669 ↗
48. Transcatheter embolization using degradable crosslinked hydrogels10.1016/j.biomaterials.2003.12.022 ↗
49. Degradable gelatin microspheres as an embolic agent: An experimental study in a rabbit renal model10.3348/kjr.2007.8.5.418 ↗
50. Genetic approaches to the cellular functions of polyamines in mammals10.1111/j.1432-1033.2004.04009.x ↗
51. Conn, M.P., and Parker, J. (2008). The Animal Research War, Palgrave MacMillan US.10.1057/9780230611993 ↗
52. Requirements and selection of an animal model
53. Standring, S. (2016). Gray’s Anatomy: The Anatomical Basis of Clinical Practice, Elsevier Limited. [41st ed.].
54. Why are tumour blood vessels abnormal and why is it important to know?10.1038/sj.bjc.6604929 ↗
55. Factors affecting early surgical intervention after uterine artery embolization10.1097/00006254-200212000-00005 ↗
56. Polyvinyl Alcohol Particle Size for Uterine Artery Embolization: A Prospective Randomized Study of Initial Use of 350–500μm Particles versus Initial Use of 500–700 μm Particles10.1016/j.jvir.2010.09.018 ↗
57. The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres10.1258/002367799780578372 ↗